The added value of H(2) antagonists in premedication regimens during paclitaxel treatment

BACKGROUND: Ranitidine, a histamine 2 blocker, is the standard of care to prevent hypersensitivity reactions (HSRs) caused by paclitaxel infusion. However, the added value of ranitidine in this premedication regimen is controversial. Therefore, we compared the incidence of HSRs during paclitaxel tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Cox, Juul M., van Doorn, Leni, Malmberg, Ruben, Oomen-de Hoop, Esther, Bosch, Tessa M., van den Bemt, Patricia M. L. A., Boere, Ingrid A., Jager, Agnes, Mathijssen, Ron H. J., van Leeuwen, Roelof W. F.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8110571/
https://ncbi.nlm.nih.gov/pubmed/33762718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01313-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados